Articles

Zosano Pharma Articles

Today 4:44 AMBenzingaNews

Bragar Eagel & Squire, P.C. is Investigating Zosano Pharma Corp. on Behalf of Zosano Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shar... See more »
October 22, 2020BenzingaNews

Zosano Pharma Investors Who Have Suffered Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.

PHILADELPHIA, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential secur... See more »
October 22, 2020The Pharma LetterNews

Zosano tanks as FDA rejects Qtrypta NDA

USA-based Zosano Pharma took another nosedive, with its shares falling 28% pre-market yesterday after... See more »
October 22, 2020MarketScreenerNews

Zosano Pharma Corp. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm

(marketscreener.com) BOSTON, Oct. 22, 2020 -- On September 30, 2020, Zosano Pharma Corp. stunned the ... See more »
October 21, 2020BenzingaNews

Why Zosano Pharma's Stock Is Trading Lower Today

Zosano Pharma (NASDAQ: ZSAN) shares are trading lower on Wednesday after the company announced it rec... See more »
October 21, 2020ForexTVNews

Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta

-FDA feedback consistent with FDA's preliminary communication in September- -Company requesting meeti... See more »
September 30, 2020ForexTVNews

Zosano Pharma Receives Preliminary FDA Communication on Qtrypta NDA

FREMONT, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) - Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
September 9, 2020BenzingaNews

Zosano Pharma to Present at the Cantor Virtual Global Healthcare Conference

FREMONT, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinic... See more »
September 3, 2020GlobeNewswirePress Release

Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference

FREMONT, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinic... See more »
May 10, 2019GlobeNewswirePress Release

Zosano Announces Full Exercise of Underwriter's Option to Purchase Additional Shares

FREMONT, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical... See more »
March 11, 2019GlobalNewswirePress Release

Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference

FREMONT, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinic... See more »
February 21, 2019GlobeNewswirePress Release

Zosano Announces Completion of the Final Milestone in the Long-Term Safety Study of Qtrypta for the Acute Treatment of Migraine Disease

FREMONT, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
May 8, 2018StreetInsiderPress Release

Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update

Zosano Pharma Corporation (NASDAQ: ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutic... See more »
October 21, 2017streetinsiderPress Release

Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital

FREMONT, Calif., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN) (“Zosano”... See more »
October 20, 2017econotimesPress Release

Zosano Enters into Common Stock Purchase Agreement with Lincoln Park Capital

Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical-stage biopharmaceutica... See more »
August 2, 2017GlobeNewswirePress Release

Zosano Pharma to Host Conference Call on Second Quarter 2017 Financial Results and Provide Operational Update

FREMONT, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinica... See more »
June 13, 2017econotimesPress Release

Zosano Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage biopharmaceutical company focused on provid... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...